ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
28.90
+0.54 (1.90%)
Sep 18, 2026, 4:00 PM EDT - Market closed
ArriVent BioPharma Employees
ArriVent BioPharma had 77 employees as of December 31, 2025. The number of employees increased by 25 or 48.08% compared to the previous year.
Employees
77
Change (1Y)
25
Growth (1Y)
48.08%
Revenue / Employee
n/a
Profits / Employee
-$2,132,597
Market Cap
1.42B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 77 | 25 | 48.08% |
| Dec 31, 2024 | 52 | 12 | 30.00% |
| Dec 31, 2023 | 40 | - | - |
| Sep 30, 2023 | 42 | - | - |
| Jun 30, 2023 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Ascentage Pharma Group International | 828 |
| Alpha Tau Medical | 121 |
| Cullinan Therapeutics | 109 |
| Bicara Therapeutics | 103 |
| Savara | 70 |
| Avalyn Pharma | 55 |
| Damora Therapeutics | 7 |
AVBP News
- 5 days ago - ArriVent Biopharma granted orphan designation for pancreatic cancer treatment - TheFly
- 4 weeks ago - ArriVent Biopharma price target raised to $47 from $44 at H.C. Wainwright - TheFly
- 4 weeks ago - ArriVent Biopharma price target lowered to $40 from $43 at Citi - TheFly
- 5 weeks ago - ArriVent BioPharma Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 5 weeks ago - ArriVent BioPharma Earnings release: Q2 2026 - Filings
- 5 weeks ago - ArriVent BioPharma Quarterly report: Q2 2026 - Filings
- 5 weeks ago - ArriVent BioPharma Slides: Corporate presentation - Filings
- 3 months ago - ArriVent BioPharma Transcript: AGM 2026 - Transcripts